Laura Pekkarinen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Insulin Resistance

Positron Emission Tomography

Top Venues

Obesity (Silver Spring, Md.)

Cognitive, affective & behavioral neuroscience

European journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, Richard Aarnio, Achol A Bhowmik, Helmi Keskinen, Sanna Laurila, Minna Lahesmaa-Hatting, Laura Pekkarinen, Henrik Isackson, Anna Kaarina Kirjavainen, Jukka Koffert, Kerstin Heurling, Lauri Nummenmaa, Eleuterio Ferrannini, Jonas Oldgren, Jan Oscarsson, Pirjo Nuutila
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study. Diabetes care (2024)
Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, Richard Aarnio, Achol A Bhowmik, Helmi Keskinen, Sanna Laurila, Minna Lahesmaa-Hatting, Laura Pekkarinen, Henrik Isackson, Anna Kaarina Kirjavainen, Jukka Koffert, Kerstin Heurling, Lauri Nummenmaa, Eleuterio Ferrannini, Jonas Oldgren, Jan Oscarsson, Pirjo Nuutila
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study. Diabetes care 47 (9) (2024)
Laura Pekkarinen, Tatu Kantonen, Vesa Oikonen, Merja Haaparanta-Solin, Richard Aarnio, Alex M Dickens, Annie von Eyken, Aino Latva-Rasku, Prince Dadson, Anna K Kirjavainen, Johan Rajander, Kari Kalliokoski, Tapani Rönnemaa, Lauri Nummenmaa, Pirjo Nuutila
Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight. Obesity (Silver Spring, Md.) 31 (7) (2023)
Laura Pekkarinen, Tatu Kantonen, Vesa Oikonen, Merja Haaparanta-Solin, Richard Aarnio, Alex M Dickens, Annie von Eyken, Aino Latva-Rasku, Prince Dadson, Anna K Kirjavainen, Johan Rajander, Kari Kalliokoski, Tapani Rönnemaa, Lauri Nummenmaa, Pirjo Nuutila
Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight. Obesity (Silver Spring, Md.) 31 (7) (2023)
Emilia Moritz, Prince Dadson, Ekaterina Saukko, Miikka-Juhani Honka, Kalle Koskensalo, Kerttu Seppälä, Laura Pekkarinen, Diego Moriconi, Mika Helmiö, Paulina Salminen, Pirjo Nuutila, Eleni Rebelos
Renal Sinus Fat Is Expanded in Patients with Obesity and/or Hypertension and Reduced by Bariatric Surgery Associated with Hypertension Remission. Metabolites 12 (7) (2022)
Laura Pekkarinen, Tatu Kantonen, Eleni Rebelos, Aino Latva-Rasku, Prince Dadson, Tomi Karjalainen, Marco Bucci, Kari Kalliokoski, Kirsi Laitinen, Noora Houttu, Anna K Kirjavainen, Johan Rajander, Tapani Rönnemaa, Lauri Nummenmaa, Pirjo Nuutila
Obesity risk is associated with brain glucose uptake and insulin resistance. European journal of endocrinology 187 (6) (2022)
Kyoungjune Pak, Tatu Kantonen, Laura Pekkarinen, Pirjo Nuutila, Lauri Nummenmaa
Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain. Journal of neuroscience research (2022)
Tatu Kantonen, Tomi Karjalainen, Laura Pekkarinen, Janne Isojärvi, Kari Kalliokoski, Valtteri Kaasinen, Jussi Hirvonen, Pirjo Nuutila, Lauri Nummenmaa
Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior. Translational psychiatry 11 (1) (2021)
Lauri Nummenmaa, Patrick Jern, Tuulia Malén, Tatu Kantonen, Laura Pekkarinen, Lasse Lukkarinen, Lihua Sun, Pirjo Nuutila, Vesa Putkinen
μ-opioid receptor availability is associated with sex drive in human males. Cognitive, affective & behavioral neuroscience (2021)
Tatu Kantonen, Laura Pekkarinen, Tomi Karjalainen, Marco Bucci, Kari Kalliokoski, Merja Haaparanta-Solin, Richard Aarnio, Alex M Dickens, Annie von Eyken, Kirsi Laitinen, Noora Houttu, Anna K Kirjavainen, Semi Helin, Jussi Hirvonen, Tapani Rönnemaa, Pirjo Nuutila, Lauri Nummenmaa
Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability. International journal of obesity (2005) (2021)